Neuromodulation device Relivion gets FDA clearance to help patients with major depression who don’t benefit from antidepressant medications

Source: https://sharpbrains.com/blog/2020/08/12/neuromodulation-device-relivion-gets-fda-clearance-to-help-patients-with-major-depression-who-dont-benefit-from-antidepressant-medications/

Neurolief wins FDA breakthrough nod for wearable neuromod for depression (Mass Device):

Neurolief announced today that it received FDA breakthrough device designation for its Relivion DP system for treating major depression.

Relivion is a wearable, non-invasive, multi-channel brain neuromodulation device designed as an adjunctive treatment to pharmaceutical management of major depressive disorder (MDD) in adults who haven’t experienced satisfactory improvement from antidepressant medications, according to a news release.

Netanya, Israel-based Neurolief’s Relivion DP is a headset-like device pla…

Source: https://sharpbrains.com/blog/2020/08/12/neuromodulation-device-relivion-gets-fda-clearance-to-help-patients-with-major-depression-who-dont-benefit-from-antidepressant-medications/

Neurolief wins FDA breakthrough nod for wearable neuromod for depression (Mass Device):

Neurolief announced today that it received FDA breakthrough device designation for its Relivion DP system for treating major depression.

Relivion is a wearable, non-invasive, multi-channel brain neuromodulation device designed as an adjunctive treatment to pharmaceutical management of major depressive disorder (MDD) in adults who haven’t experienced satisfactory improvement from antidepressant medications, according to a news release.

Netanya, Israel-based Neurolief’s Relivion DP is a headset-like device pla…

What Do You Think?

comments

Translate »